Managed Healthcare Executive September 6, 2023
Denise Myshko

PBM transparency and data reporting requirements are likely to be part of a larger healthcare bill that Congress will work on this fall.

Any federal bill regulating the pharmacy benefit management (PBM) industry that makes it Pres. Joe Biden’s desk will likely be focused on transparency issues and not on providing broad changes to the industry, according to speakers at the Pharmacy Benefit Management Institute’s annual conference in Orlando.

Over the last two legislative sessions, many bills have been introduced in the both the House and the Senate. But there are four bills that are important to watch, said Patrick Cooney, president, The Federal Group. “On the heels of the Inflation Reduction Act, PBM legislation has blossomed,” he said.

The...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Congress / White House, Govt Agencies, Pharma, Pharma / Biotech, Regulations
Why One Startup CEO Is Excited About the White House’s New AI Czar Role
ASCs prepare for the Trump administration: 5 notes
Telehealth survives in federal spending plan, but fight for longer extension continues
Congress Passes Extension to Key Telehealth Payment Policies
6 key health policy areas to watch in the new year

Share This Article